Remedium Lifecare Ltd

AI

Remedium Lifecare Ltd

₹ 0.25 0.00%
20 Nov 2:44 p.m.
About

Supha Pharmachem Ltd, formerly Remedium Lifecare, is a pharmaceutical supply-chain trader of APIs, advanced intermediates, KSMs/CRMs and other pharma chemicals for domestic and export markets. It operates through the Indian parent and Singapore subsidiary Remlife Global Pte Ltd and entered CIRP on March 17, 2026. [1]

Key Points

Entity & consolidation:
The Co's name changed from Remedium Lifecare to Supha Pharmachem effective December 15, 2025.[1]
Its Singapore subsidiary Remlife Global, incorporated on Sep,24, contributed ₹102.48 crore revenue and ₹8.55 crore PAT in Q2 FY26 versus group revenue/PAT of ₹111.06 crore/₹8.62 crore. [2]

  • Market Cap ₹ 22.0 Cr.
  • Current Price ₹ 0.25
  • High / Low ₹ 1.34 / 0.23
  • Stock P/E 10.4
  • Book Value ₹ 1.19
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE 4.85 %
  • Face Value ₹ 1.00

Pros

  • Stock is trading at 0.21 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 1.13%
  • Earnings include an other income of Rs.10.8 Cr.
  • Company has high debtors of 695 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 (S) Dec 2022 (S) Mar 2023 (S) Jun 2023 (S) Sep 2023 (S) Dec 2023 (S) Mar 2024 (S) Jun 2024 (S) Sep 2024 (S) Dec 2024 (S) Mar 2025 Jun 2025 Sep 2025
158.45 176.48 75.58 330.46 468.57 1,834.18 1,408.49 77.70 25.08 38.15 264.32 113.37 111.06
156.31 174.95 78.48 323.18 462.23 1,779.48 1,443.51 77.31 20.62 43.63 264.78 111.50 103.68
Operating Profit 2.14 1.53 -2.90 7.28 6.34 54.70 -35.02 0.39 4.46 -5.48 -0.46 1.87 7.38
OPM % 1.35% 0.87% -3.84% 2.20% 1.35% 2.98% -2.49% 0.50% 17.78% -14.36% -0.17% 1.65% 6.65%
0.06 0.02 0.00 0.00 4.08 14.12 2.89 1.89 0.82 7.43 0.66 3.48 3.25
Interest 0.00 0.02 -0.10 0.00 0.00 0.03 3.85 0.00 2.81 0.88 1.59 -0.36 0.19
Depreciation 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Profit before tax 2.19 1.52 -2.81 7.27 10.41 68.78 -35.99 2.27 2.46 1.06 -1.40 5.71 10.44
Tax % 0.00% 0.00% 70.11% 27.79% 37.27% 33.38% 49.24% 27.75% 27.64% 27.36% 45.71% 18.56% 17.34%
2.19 1.52 -4.78 5.25 6.53 45.82 -53.72 1.64 1.78 0.76 -2.05 4.65 8.62
EPS in Rs 0.04 0.03 -0.08 0.09 0.11 0.79 -0.93 0.03 0.03 0.01 -0.04 0.05 0.10
Raw PDF

(S): Standalone figures, shown where consolidated figures are not available.

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 (S) Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025
1 2 4 1 0 0 3 90 505 510 4,040 405
1 2 4 1 0 0 2 89 503 502 4,006 404
Operating Profit 0 -0 -0 -0 0 -0 0 1 2 8 34 1
OPM % 3.4% -8% -8% -7% 0.0% -44% 14% 0.8% 0.4% 1.6% 0.8% 0.3%
0 1 0 0 0 0 0 0 0 0 21 11
Interest 0 0 0 0 0 0 0 0 0 0 5 8
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 1 0 0 0 0 0 1 2 7 50 4
Tax % 50% 21% 0% 0% 0% 100% 24% 26% 29% 27% 35% 51%
0 1 0 0 0 0 0 0 1 5 33 2
EPS in Rs 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.09 0.57 0.04
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%

(S): Standalone figures, shown where consolidated figures are not available.

Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: -22%
3 Years: -76%
1 Year: -81%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 (S) Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 Sep 2025
Equity Capital 4 4 4 4 4 4 4 4 4 4 10 40 88
Reserves -0 -1 -1 -1 -1 -1 -0 0 1 7 33 4 17
1 0 0 0 0 0 0 10 0 0 58 1,141 1,088
1 3 2 0 0 0 1 24 219 1,144 1,847 535 430
Total Liabilities 6 6 5 3 3 4 4 39 224 1,154 1,948 1,720 1,623
2 1 0 0 0 0 0 0 0 0 0 0 6
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
4 4 5 3 3 4 4 38 224 1,154 1,948 1,720 1,617
Total Assets 6 6 5 3 3 4 4 39 224 1,154 1,948 1,720 1,623

(S): Standalone figures, shown where consolidated figures are not available.

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 (S) Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025
0 -1 0 -0 -0 -0 -10 11 20 -74 -1,135
0 1 0 0 1 -0 -0 -0 -0 0 0
-0 -0 0 0 0 0 10 -11 -0 54 1,136
Net Cash Flow -0 0 0 -0 1 -0 -0 1 20 -20 1
Free Cash Flow 0 0 0 -0 -0 -0 -10 11 20 -74 -1,135
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -53% 453% -78% 114% -50% -1,393% 641% 281% -165% -90,064%

(S): Standalone figures, shown where consolidated figures are not available.

Ratios

Consolidated / View Standalone

Mar 2007 (S) Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025
Debtor Days 120 341 265 596 2,117 319 189 96 46 123 83 695
Inventory Days 1,129 243 78 0 0 5 12 247
Days Payable 102 438 129 62 65 459
Cash Conversion Cycle 1,147 146 214 596 2,117 319 189 96 46 67 30 483
Working Capital Days 566 107 200 524 2,159 4,745 323 54 2 -8 4 38
ROCE % 1% 1% 0% 1% 1% 11% 7% 18% 103% 100%

(S): Standalone figures, shown where consolidated figures are not available.

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
FOB Value of Exports
Rs. Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
CIF Value of Imports
Rs. Lakhs ・Standalone data
Number of Permanent Employees (including Directors)
count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.11% 1.13% 1.13% 1.13%
0.00% 0.04% 0.08% 0.04% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.70%
98.88% 98.84% 98.81% 98.86% 98.85% 98.89% 98.89% 98.89% 98.89% 98.87% 98.87% 97.17%
No. of Shareholders 7051,7303,9883,85915,58726,46467,40473,6371,10,4221,13,5431,14,1191,11,269

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents